Profile
Maggie Massam worked as a Director of Client Services at Prime Medical Services, Inc. and as a Vice President at Cline, Davis & Mann LLC.
She also worked as a Senior Vice President of Global Marketing at Abraxis BioScience, Inc. from 2009 to 2011.
Former positions of Maggie Massam
| Companies | Position | End |
|---|---|---|
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Sales & Marketing | 2011-03-29 |
Cline, Davis & Mann LLC
 Cline, Davis & Mann LLC Advertising/Marketing ServicesCommercial Services Cline, Davis & Mann LLC provides health care marketing services. It offers advertising, sales-force support, relationship marketing, account planning, and medical education services. The company was founded by Morgan E. Cline, Clyde P. Davis, and Fred Mann in 1984 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| Prime Medical Services, Inc. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
| Prime Medical Services, Inc. | Health Services |
Cline, Davis & Mann LLC
Cline, Davis & Mann LLC Advertising/Marketing ServicesCommercial Services Cline, Davis & Mann LLC provides health care marketing services. It offers advertising, sales-force support, relationship marketing, account planning, and medical education services. The company was founded by Morgan E. Cline, Clyde P. Davis, and Fred Mann in 1984 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Maggie Massam
